NO980215L - Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater - Google Patents
Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivaterInfo
- Publication number
- NO980215L NO980215L NO980215A NO980215A NO980215L NO 980215 L NO980215 L NO 980215L NO 980215 A NO980215 A NO 980215A NO 980215 A NO980215 A NO 980215A NO 980215 L NO980215 L NO 980215L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- pharmaceutical compositions
- compositions containing
- drugs
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9514821.9A GB9514821D0 (en) | 1995-07-19 | 1995-07-19 | Galanthamine derivatives |
PCT/FR1996/001139 WO1997003987A1 (fr) | 1995-07-19 | 1996-07-19 | Nouveaux derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO980215D0 NO980215D0 (no) | 1998-01-16 |
NO980215L true NO980215L (no) | 1998-01-16 |
Family
ID=10777948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO980215A NO980215L (no) | 1995-07-19 | 1998-01-16 | Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater |
Country Status (16)
Country | Link |
---|---|
US (1) | US5958903A (da) |
EP (1) | EP0839149B9 (da) |
JP (1) | JP4177894B2 (da) |
AT (1) | ATE264332T1 (da) |
AU (1) | AU6662396A (da) |
CA (1) | CA2227235C (da) |
DE (1) | DE69632194T2 (da) |
DK (1) | DK0839149T3 (da) |
ES (1) | ES2218596T3 (da) |
GB (1) | GB9514821D0 (da) |
IL (1) | IL122739A0 (da) |
MX (1) | MX9800407A (da) |
NO (1) | NO980215L (da) |
PT (1) | PT839149E (da) |
WO (1) | WO1997003987A1 (da) |
ZA (1) | ZA966163B (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1891954A3 (en) * | 1998-09-30 | 2009-01-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
AU1738800A (en) * | 1998-11-23 | 2000-06-13 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
HUP0104778A3 (en) | 1998-12-24 | 2004-05-28 | Janssen Pharmaceutica Nv | Controlled release galantamine composition |
US8603546B2 (en) * | 1999-01-11 | 2013-12-10 | Herbaceuticals Inc. | Herbal supplement for increased muscle strength and endurance for athletes |
US6159476A (en) * | 1999-01-11 | 2000-12-12 | Herbaceuticals | Herbal supplement for increased muscle strength and endurance for athletes |
DE69913138T2 (de) * | 1999-03-31 | 2004-08-26 | Eisai Co., Ltd. | Stabilisierte zusammensetzung mit nootropen wirkstoffen |
CA2368966A1 (en) * | 2000-03-31 | 2001-10-11 | Sanochemia Pharmazeutika Aktiengesellschaft | New derivatives and analogues of galanthamine |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
JP4721386B2 (ja) * | 2001-07-10 | 2011-07-13 | 第一三共株式会社 | 新規ガランタミン類縁体 |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
EP1681291A1 (de) * | 2002-03-25 | 2006-07-19 | Sanochemia Pharmazeutika Aktiengesellschaft | Verfahren zur Herstellung von Norgalanthamin, Ihren Isomeren, Salzen und Hydraten |
WO2005030332A2 (de) * | 2003-09-29 | 2005-04-07 | Sanochemia Pharmazeutika Ag | Verwendung von galanthamin und seinen derivaten zum herstellen von arzneimitteln |
AT414125B (de) * | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
WO2005065662A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
US20050191349A1 (en) * | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
DK1895994T3 (da) * | 2005-05-13 | 2010-12-20 | Alza Corp | Multilagsmedikamentleveringssystem med barriere mod reservoirmaterialeflow |
US20070104771A1 (en) * | 2005-09-23 | 2007-05-10 | Jay Audett | Transdermal galantamine delivery system |
AU2009290396B2 (en) * | 2008-09-11 | 2014-11-06 | I.B.R. Israeli Biotechnology Research Ltd. | Leucojum bulb extracts and use thereof |
US20120129838A1 (en) * | 2009-04-24 | 2012-05-24 | The Industry & Academic Cooperation In Chungnam National University | Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
US4735169A (en) * | 1986-09-03 | 1988-04-05 | Nordson Corporation | Adhesive applicator assembly |
KR100195399B1 (ko) * | 1987-05-04 | 1999-06-15 | 보니데이비스 | 알쯔하이머 병 치료용 의약 |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US5428159A (en) * | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
-
1995
- 1995-07-19 GB GBGB9514821.9A patent/GB9514821D0/en active Pending
-
1996
- 1996-07-19 AU AU66623/96A patent/AU6662396A/en not_active Abandoned
- 1996-07-19 ZA ZA9606163A patent/ZA966163B/xx unknown
- 1996-07-19 PT PT96926431T patent/PT839149E/pt unknown
- 1996-07-19 DE DE69632194T patent/DE69632194T2/de not_active Expired - Lifetime
- 1996-07-19 DK DK96926431T patent/DK0839149T3/da active
- 1996-07-19 MX MX9800407A patent/MX9800407A/es unknown
- 1996-07-19 US US08/983,309 patent/US5958903A/en not_active Expired - Lifetime
- 1996-07-19 IL IL12273996A patent/IL122739A0/xx unknown
- 1996-07-19 CA CA2227235A patent/CA2227235C/fr not_active Expired - Fee Related
- 1996-07-19 ES ES96926431T patent/ES2218596T3/es not_active Expired - Lifetime
- 1996-07-19 AT AT96926431T patent/ATE264332T1/de active
- 1996-07-19 WO PCT/FR1996/001139 patent/WO1997003987A1/fr active IP Right Grant
- 1996-07-19 JP JP50637297A patent/JP4177894B2/ja not_active Expired - Fee Related
- 1996-07-19 EP EP96926431A patent/EP0839149B9/fr not_active Expired - Lifetime
-
1998
- 1998-01-16 NO NO980215A patent/NO980215L/no unknown
Also Published As
Publication number | Publication date |
---|---|
MX9800407A (es) | 1998-04-30 |
EP0839149B9 (fr) | 2005-03-09 |
DE69632194T2 (de) | 2005-03-17 |
ZA966163B (en) | 1997-02-10 |
NO980215D0 (no) | 1998-01-16 |
PT839149E (pt) | 2004-08-31 |
ATE264332T1 (de) | 2004-04-15 |
JP4177894B2 (ja) | 2008-11-05 |
GB9514821D0 (en) | 1995-09-20 |
CA2227235A1 (fr) | 1997-02-06 |
WO1997003987A1 (fr) | 1997-02-06 |
EP0839149A1 (fr) | 1998-05-06 |
JPH11509541A (ja) | 1999-08-24 |
CA2227235C (fr) | 2010-08-31 |
EP0839149B1 (fr) | 2004-04-14 |
ES2218596T3 (es) | 2004-11-16 |
AU6662396A (en) | 1997-02-18 |
IL122739A0 (en) | 1998-08-16 |
DK0839149T3 (da) | 2004-08-09 |
US5958903A (en) | 1999-09-28 |
DE69632194D1 (de) | 2004-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO980215L (no) | Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
NO960067L (no) | Nytt farmasöytisk preparat | |
GEP20012375B (en) | Isothiazolones, Pharmaceutical Composition on Their Basis and Method for Obtaining the Same | |
HUP9901304A3 (en) | Piperazine and piperidine derivatives with analgesic effect, process for their preparation and pharmaceutical compositions containing them | |
NO20014102L (no) | Nye tricykliske forbindelser og deres anvendelse innenfor medisin, fremgangsmåte for deres fremstilling og farmasöytisksammensetning som inneholder dem | |
DE122011100032I1 (de) | Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer. | |
MX9600857A (es) | Forma de dosificacion i en tabletas, con unidades multiples. | |
NO20002787L (no) | Nye forbindelser | |
EE03253B1 (et) | (R)-5-karbamoüül-8-fluoro-3-N,N-diasendatud-amino-3,4-dihüdro-2H-1-bensopüraani d, nende valmistamise protsess ja neid sisaldavad ravimkoostised | |
GEP20053501B (en) | Core Tablet for Controlled Release of Gliclazide after Oral Administration | |
GEP20033028B (en) | Heterocyclic Compounds as Inhibitors of Rotamase Enzymes, Method for Their Production, Pharmaceutical Composition Containing Them and Use Thereof | |
DE69632193D1 (de) | Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel | |
NO982778D0 (no) | Morfinderivater med smertestillende virkning | |
DE60121431D1 (de) | Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
NO995685L (no) | Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger | |
NO20006547L (no) | Salter av paroxetine | |
GEP20012518B (en) | Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine | |
DE69905490D1 (de) | Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen | |
JO1880B1 (en) | Format 1 for multi-unit calibration discs | |
NO930942L (no) | Nye 17-beta-oestradiolderivater, fremgangsmaater for deres fremstilling og legemiddel inneholdende disse forbindelser | |
ATE221068T1 (de) | Anellierte beta-carboline |